DEF: Manhattan Bridge Capital Sets Annual Meeting Date

Sentiment:

Proxy Statement


Manhattan Bridge Capital, Inc. has announced its 2026 Annual Meeting of Shareholders, scheduled for June 18, 2026, to elect directors and approve independent auditors.

Summary

  • Manhattan Bridge Capital, Inc. is holding its 2026 Annual Meeting of Shareholders on Thursday, June 18, 2026, at 9:00 a.m. local time.
  • The meeting will take place at the offices of Sullivan & Worcester LLP, 1251 Avenue of the Americas, New York, NY 10020.
  • Key agenda items include the election of six directors and an advisory approval of the appointment of Hoberman & Lesser CPAs, LLP as the company's independent auditors for the fiscal year ending December 31, 2026.
  • The record date for determining shareholders entitled to vote is April 24, 2026, with 11,429,351 shares of common stock outstanding on that date.
  • Shareholders are urged to vote by proxy to ensure a quorum and save the company expenses.
  • Proxy materials are available online at www.proxyvote.com, and paper copies can be requested.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is a routine procedural document for an annual shareholder meeting and does not contain significant new financial performance data or strategic announcements.

Positives

  • The company is holding its annual meeting as scheduled, indicating ongoing operational and governance processes.
  • All current directors are nominated for re-election, suggesting board stability.
  • The company has a clear process for shareholder communication and proposal submission.
  • Independent directors constitute a majority of the board and its key committees (Audit, Compensation, Corporate Governance and Nominating).

Negatives

  • The filing does not contain financial performance data for the most recent fiscal year (2025), as it is a proxy statement focused on governance and meeting logistics.
  • The company's net income decreased by approximately 8.6% from 2024 to 2025, primarily due to a slowdown in new loan originations.

Risks

  • The company's net income decrease in 2025 was primarily due to a slowdown in new loan originations, indicating potential market or operational challenges in its core business.
  • The company's total shareholder return (TSR) decreased from 21.9% in 2024 to (8.8%) in 2025, suggesting a decline in market performance relative to the previous year.
  • The insider trading policy prohibits speculative transactions, including hedging and derivatives, which could limit certain risk management strategies for insiders.

Future Outlook

The filing is a proxy statement for an upcoming annual meeting and does not contain specific forward-looking financial guidance. However, it outlines the agenda for the meeting, including the election of directors and the approval of auditors for the fiscal year ending December 31, 2026.

Management Comments

  • "It is important that your shares be represented at this meeting to ensure the presence of a quorum."
  • "Whether or not you plan to attend the meeting, we hope that you will have your shares represented by signing, dating and returning your proxy in the enclosed envelope, which requires no postage if mailed in the United States, as soon as possible."
  • "Thank you for your continued support."

Industry Context

StockSavvy.ai notes that this filing is typical for a publicly traded company preparing for its annual shareholder meeting, focusing on corporate governance, director elections, and auditor ratification. The details provided are standard for such disclosures.

Comparison to Industry Standards

  • The election of directors requires a plurality of votes cast, which is a common standard in U.S. corporate governance.
  • The advisory approval of independent auditors requires a majority of votes cast, a standard practice for shareholder ratification.
  • The company's board structure, with Audit, Compensation, and Corporate Governance & Nominating Committees composed of independent directors, aligns with best practices recommended by stock exchanges like Nasdaq.
  • The compensation structure for directors, including annual cash retainers and meeting attendance fees, is consistent with industry norms for companies of similar size and scope.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director ElectionElection of six (6) directors to serve until the next Annual Meeting of Shareholders.June 18, 2026Standard annual process to ensure board continuity and representation.
Auditor Appointment ApprovalAdvisory approval of the appointment of Hoberman & Lesser CPAs, LLP as the Company's independent auditors for the fiscal year ending December 31, 2026.June 18, 2026Shareholder input on auditor selection, though final appointment rests with the Audit Committee.
Board Leadership StructureThe Board has determined that having Mr. Ran serve as both Chairman and Chief Executive Officer is in the best interest of shareholders, leveraging his extensive knowledge and fostering communication.OngoingMaintains a combined leadership role, which the Board believes is currently optimal for the company.
Risk OversightThe Board oversees risk management, encouraging a culture that integrates risk management into corporate strategy and daily operations.OngoingDemonstrates a commitment to proactive risk identification and management.

Related Party Transactions

  • No director, executive officer, principal stockholder holding at least 5% of our Common Shares, or any family member thereof, had or will have any material interest, direct or indirect, in any transaction, or proposed transaction, during the year 2025 in which the amount involved in the transaction exceeded or exceeds the lesser of $120,000 or one percent of our total assets at the end of 2025, other than compensation arrangements.

Stakeholder Impact

  • Shareholders: Will vote on director elections and auditor appointment, influencing board composition and oversight.
  • Management: Executive compensation details are disclosed, and employment agreements are outlined.
  • Auditors: Hoberman & Lesser CPAs, LLP is proposed for reappointment, subject to shareholder advisory approval.

Next Steps

  • Shareholders will vote on the election of six directors.
  • Shareholders will provide advisory approval for the appointment of Hoberman & Lesser CPAs, LLP as independent auditors for fiscal year 2026.
  • The Board of Directors will consider shareholder feedback on auditor appointment.
  • The company will hold its 2026 Annual Meeting of Shareholders on June 18, 2026.

Key Dates

DateDescription
2026-04-24Record date for determining shareholders entitled to notice of and to vote at the Annual Meeting.
2026-05-08Date of the Notice of Meeting and Proxy Statement.
2026-06-18Date of the 2026 Annual Meeting of Shareholders.
2027-01-08Deadline for submitting shareholder proposals for inclusion in the 2027 Annual Meeting proxy materials.
2027-03-24Deadline for shareholders to advise the Secretary of proposals to be presented at the next annual meeting without inclusion in proxy materials.

Recommendation

hold

This filing is a routine proxy statement for an annual meeting and does not contain new financial performance data or strategic shifts that would warrant a buy or sell recommendation. It confirms ongoing governance processes and upcoming shareholder votes. The slight decrease in net income and TSR in 2025, while noted, is not significant enough based solely on this document to alter a 'hold' position.

Keywords

Proxy Statement, Annual Meeting, Shareholders, Directors, Independent Auditors, Corporate Governance, Manhattan Bridge Capital, DEF 14A, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.